Date Posted: 2011-11-23 13:26 New Issue: Sphere Medical Holding Plc Sphere Medical, based in Cambridge, UK, is a company completing the development of a range of in vitro diagnostic products designed to provide significant improvements in patient management in a number of hospital specialities. Sphere Medical's products are expected to allow near real time measurement of blood gases, various electrolytes, glucose and drug levels with laboratory accuracy, at the patient's bedside. This information can be used in a wide range of medical applications and is intended to enable faster clinical decision making and consequently to improve the management of patients.
Sphere Medical's two most advanced products based on its proprietary microanalyser technology are a disposable patient-attached arterial blood analyser for use in the intensive care unit or operating room ('Proxima') and an in-line blood monitor for patients undergoing cardiac bypass surgery. In addition, Sphere Medical has a propofol measurement device ('Pelorus 1000'). In each case, these products will ultimately target patients requiring close monitoring and frequent levels of blood testing.
Listing exchange: AIM
Expected first day of trading: 2011-11-17
Expected money raised: £14m Any information, prospectus or other document, or any hypertext link to any of the aforesaid should not be construed as advice on investments or a personal recommendation by ALL IPO plc and is being offered on an execution-only basis. Any decision to invest should be made only after careful consideration of the relevant documentation and particularly after acceptance of the full terms and conditions relating to the specific investment opportunity. Share prices, values and income can go down as well as up and you may get back less than the amount you invested. If in doubt about the suitability of investments referred to in this communication and on our website, you should consult an investment adviser authorised under the Financial Services and Markets Act 2000. |
